This inventor holds 1 USPTO granted patent. Top assignee: Yale University. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Mao-Chin Liu: Innovator in Nucleoside Research
Introduction
Mao-Chin Liu is a prominent inventor based in North Haven, CT (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel nucleosides. His work has implications for antiviral, antineoplastic, and antibacterial applications.
Latest Patents
Mao-Chin Liu holds 1 patent for his invention titled "Nucleosides and related processes, pharmaceutical compositions and methods." This invention provides novel nucleosides that are useful in a wide variety of applications. The preferred embodiments include novel 2 halogen-substituted, 3 halogen-substituted, and 2',3′-dihalogen-substituted analogues of 3-deazaadenosine, as well as novel 3 halogen-substituted analogues of 3-deazaguanosine. The compounds developed in this invention, such as 4-Amino-6-fluoro-1-(β-D-ribofuranosyl)imidazo[4,5-c]pyridine and 6-Amino-7-bromo-1,5-dihydro-1-β-D-ribofuranosylimidazo[4,5-c]pyridin-4-one, have exhibited potent antiviral and anticancer activity in vitro. These compounds are also useful in the concomitant treatment of bacterial infections associated with viral infections like AIDS.
Career Highlights
Mao-Chin Liu is affiliated with Yale University, where he continues to advance his research in nucleoside chemistry. His innovative work has positioned him as a key figure in the pharmaceutical field, contributing to the development of effective treatments for various diseases.
Collaborations
Mao-Chin Liu has collaborated with notable colleagues, including Alan C Sartorelli and Yung-Chi Cheng. These collaborations have further enhanced the impact of his research and innovations in the field.
Conclusion
Mao-Chin Liu's contributions to nucleoside research exemplify the importance of innovation in developing new pharmaceutical treatments. His work continues to influence the fields of antiviral and anticancer therapies, showcasing the potential of novel compounds in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile